Boost Your Profits with Deep Trend Analysis: Swing Trader Generates 6.24% Returns for PFE
Swing Trader: Deep Trend Analysis (TA) Generates 6.24% for PFE
Pfizer Inc. (PFE) has caught the attention of swing traders as its recent trend analysis indicates the potential for a significant upward movement. The stock displayed a bullish signal by breaking its lower Bollinger Band on June 26, 2023. This development suggests that PFE may experience a price jump and potentially regain momentum toward the middle band.
Traders who closely follow technical analysis may find this breakout compelling, considering buying the stock or exploring call options. Historical data provides some insight into the possible outcome, as 28 out of 40 instances where PFE's price broke its lower Bollinger Band resulted in a further increase in the following month. This historical success rate implies that there is a 70% chance of a continued upward trend for PFE.
Bollinger Bands, a widely used technical indicator, consist of a moving average (the middle band) and two standard deviation lines (the upper and lower bands). When the price breaks below the lower Bollinger Band, it suggests that the stock may be oversold and due for a potential bounce back.
Swing traders, who aim to capture short to medium-term price movements, can leverage deep trend analysis techniques to identify such opportunities. By studying chart patterns, indicators, and market dynamics, swing traders seek to capitalize on potential price fluctuations.
It's important to note that while deep trend analysis offers valuable insights into potential market movements, trading always carries inherent risks. Traders should exercise caution and employ appropriate risk management strategies, such as setting stop-loss orders and diversifying their portfolios.
As swing traders evaluate PFE's current situation, the signs are indicating a favorable outlook. If the stock manages to rebound from its lower Bollinger Band and move toward the middle band, traders may seize this opportunity for potential gains.
PFE in -4.52% downward trend, declining for three consecutive days on May 07, 2025
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where PFE declined for three days, in of 332 cases, the price declined further within the following month. The odds of a continued downward trend are .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on May 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PFE as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
PFE broke above its upper Bollinger Band on April 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PFE entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PFE's RSI Oscillator exited the oversold zone, of 45 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for PFE just turned positive on April 23, 2025. Looking at past instances where PFE's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PFE advanced for three days, in of 269 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.763) is normal, around the industry mean (5.632). P/E Ratio (74.919) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.281) is also within normal values, averaging (3.004). Dividend Yield (0.060) settles around the average of (0.161) among similar stocks. P/S Ratio (2.674) is also within normal values, averaging (3.643).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PFE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PFE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a manufacturer of vaccines and injectable biologic medicines
Industry PharmaceuticalsMajor